Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 3
1979 1
1981 1
1986 1
1987 5
1988 14
1989 11
1990 4
1991 8
1992 4
1993 9
1994 17
1995 18
1996 24
1997 14
1998 24
1999 19
2000 22
2001 17
2002 14
2003 13
2004 15
2005 16
2006 22
2007 21
2008 21
2009 28
2010 17
2011 19
2012 22
2013 22
2014 25
2015 17
2016 14
2017 19
2018 14
2019 13
2020 12
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

518 results
Results by year
Filters applied: . Clear all
Page 1
The emerging complexity of gene fusions in cancer.
Mertens F, Johansson B, Fioretos T, Mitelman F. Mertens F, et al. Nat Rev Cancer. 2015 Jun;15(6):371-81. doi: 10.1038/nrc3947. Nat Rev Cancer. 2015. PMID: 25998716 Review.
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih IeM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H. Killela PJ, et al. Among authors: mertens f. Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6021-6. doi: 10.1073/pnas.1303607110. Epub 2013 Mar 25. Proc Natl Acad Sci U S A. 2013. PMID: 23530248 Free PMC article.
Translocation-related sarcomas.
Mertens F, Antonescu CR, Hohenberger P, Ladanyi M, Modena P, D'Incalci M, Casali PG, Aglietta M, Alvegård T. Mertens F, et al. Semin Oncol. 2009 Aug;36(4):312-23. doi: 10.1053/j.seminoncol.2009.06.004. Semin Oncol. 2009. PMID: 19664492 Review.
Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.
Buddingh EP, Kuijjer ML, Duim RA, Bürger H, Agelopoulos K, Myklebost O, Serra M, Mertens F, Hogendoorn PC, Lankester AC, Cleton-Jansen AM. Buddingh EP, et al. Among authors: mertens f. Clin Cancer Res. 2011 Apr 15;17(8):2110-9. doi: 10.1158/1078-0432.CCR-10-2047. Epub 2011 Mar 3. Clin Cancer Res. 2011. PMID: 21372215 Free article.
Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
Puls F, Agaimy A, Flucke U, Mentzel T, Sumathi VP, Ploegmakers M, Stoehr R, Kindblom LG, Hansson M, Sydow S, Arbajian E, Mertens F. Puls F, et al. Among authors: mertens f. Am J Surg Pathol. 2020 May;44(5):594-606. doi: 10.1097/PAS.0000000000001423. Am J Surg Pathol. 2020. PMID: 31913156
Deep sequencing of myxoinflammatory fibroblastic sarcoma.
Arbajian E, Hofvander J, Magnusson L, Mertens F. Arbajian E, et al. Among authors: mertens f. Genes Chromosomes Cancer. 2020 May;59(5):309-317. doi: 10.1002/gcc.22832. Epub 2020 Jan 31. Genes Chromosomes Cancer. 2020. PMID: 31898851
518 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page